Nicole R. Hadas, SVP, General Counsel, Secretary at Akebia Therapeutics, Inc. (AKBA), sold 14,053 shares at $19.95 ($280K) on 2017-10-02, disclosed to the SEC on 2017-10-04.
Open-market sale of $280k AKBA by SVP, General Counsel, Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.64 | 1,553 | $31K | 10.9% |
| 2 | $19.95 | 6,250 | $125K | 44.6% |
| 3 | $19.95 | 6,250 | $125K | 44.6% |
| Total | $19.92 avg | 14,053 | $280K | 100% |
| Filing → |
| AKBA | SELL | 2024-02-29 | $11K | — | Filing → |
| AKBA | SELL | 2023-05-25 | $154K | — | Filing → |
| AKBA | SELL | 2023-03-03 | $11K | — | Filing → |